Search
for
Did you mean Estrogen Receptor-Positive Breast Cancer?
Sort by
Research 30 of 1000+
- The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
- Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Androgen- and Estrogen-Secreting Adrenal Cancers
- The premature catagen induced by estrogen was accompanied with advance apoptosis of precortex cells.
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Drug safety evaluation of exemestane
- Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer
- 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Ductal breast cancer in a male patient
- Systemic testosterone induces structural, immunological, and sex steroid receptor changes in human XX skin
- Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α
- Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healing
- The role of inflammation and immunity in the pathogenesis of androgenetic alopecia.
- Estrogens and aging skin
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- Regulatory roles of androgens in cutaneous wound healing
- Aromatase inhibitors induce ‘male pattern hair loss’ in women?
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Postmenopausal hormone replacement therapy and changes in skin connective tissue
- Female pattern hair loss possibly caused by tamoxifen: Androgen receptor expression in the outer root sheath in the affected area